Tellus Therapeutics
Hillsborough
About Tellus Therapeutics
Tellus Therapeutics is developing novel small molecules derived from human maternal breast milk for the treatment of newborns with perinatal brain injury. It was founded in 2018 and is based in Hillsborough, North Carolina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $53.5M
- Last round: Series Unknown (Feb 2023)
- Website: tellustherapeutics.com
- Phone: 919-491-4995
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/tellus-therapeutics-15938 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.